Comments
Loading...

Galmed Pharmaceuticals

GLMDNASDAQ
Logo brought to you by Benzinga Data
$10.51
-4.59-30.40%
After Hours: 9:29 AM EDT
15 minutes delayed

Galmed Pharmaceuticals (NASDAQ:GLMD) Stock, Earnings Estimates, EPS, And Revenue

Galmed Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
May 30
EPS
$-2.760
Quarterly Revenue
$0K
Annual Revenue
(as of Jun 30)

Analyze the earnings history of Galmed Pharmaceuticals using advanced sorting and filters.

Data brought to you by Benzinga APIs

Galmed Pharmaceuticals (GLMD) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Mar 20242024-04-04$-11.76$-3.84-206.3 %
Sep 20232023-11-22$-2.88$-3.6020.0 %
Jun 20232023-08-09$-11.40$-4.08-179.4 %
Mar 20232023-06-01$-13.08$-18.0027.3 %

Galmed Pharmaceuticals (GLMD) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %

FAQ

Q

When is Galmed Pharmaceuticals (NASDAQ:GLMD) reporting earnings?

A

Galmed Pharmaceuticals (GLMD) is scheduled to report earnings on November 20, 2024. The last reported earnings were for reported on May 30, 2024 for Q1.

Q

What were the latest earnings per share (EPS) for Galmed Pharmaceuticals (NASDAQ:GLMD)?

A

The Actual EPS was $-2.76, which missed the estimate of $0.00.

Q

What were Galmed Pharmaceuticals’s (NASDAQ:GLMD) revenues?

A

The Actual Revenue was $0K, which hit the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.